10X Genomics Inc vs Global X Uranium ETF — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Global X Uranium ETF trades at $40.5. The key difference: 10X Genomics Inc is trading nearer its 52-week high, Global X Uranium ETF nearer its low. Which is the better fit depends on your goals.
| TXG | URA | |
|---|---|---|
Market Cap | $5.48B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $45.80 | $61.81 |
52-Week Low | $11.34 | $36.45 |
Enterprise Value | $5.02B | — |
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →